Calidi Biotherapeutics, Inc.
CLDI- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001855485
No open-market purchases or sales by Calidi Biotherapeutics, Inc. insiders were filed in the last 90 days; 23 institutions reported holding it in 13F filings for Q2 2026, worth $89.3K in total; no superinvestor holds it.
Other share classesCLDWW
Q3 2025 vs. Q2 2025
How the institutions holding Calidi Biotherapeutics, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Of which not filed for Q3 2025 | Q3 2025 | Change |
|---|---|---|---|---|
| Holders | 35 | 1 | 22 | −12 |
| SharesConverted for a 1-for-12 split | 238.0K | 833.33 | 232.5K | −4.60K (−1.9%) |
| Value | $655.8K | $2.00K | $353.6K | −$300.3K (−45.9%) |
1 institution that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (5)
Institutions that held Calidi Biotherapeutics, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Warberg Asset Management LLC | 18,705 | $28.4K | 0.01% |
| RS Crum Inc. | 15,256 | $23.2K | 0.01% |
| Apollo Management Holdings, L.P. | 1,042 | $1.58K | 0.00% |
| FMR LLC | 125 | $190 | 0.00% |
| Reyes Financial Architecture, Inc. | 100 | $152 | 0.00% |
Sold out (17)
Institutions that held Calidi Biotherapeutics, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Armistice Capital, LLC | 792,000 | $182.2K |
| Bank of Montreal | 422,500 | $97.2K |
| CPR Investments Inc. | 101,000 | $23.2K |
| Red Wave Investments LLC | 80,828 | $18.6K |
| Citadel Advisors LLC | 71,196 | $16.4K |
| State Street Corp | 61,290 | $14.1K |
| Northern Trust Corp | 48,693 | $11.2K |
| Drive Wealth Management, LLC | 45,000 | $10.3K |
| HRT Financial LP | 43,609 | $10.0K |
| Raymond James Financial Inc | 31,100 | $7.15K |
| Delta Investment Management, LLC | 21,023 | $4.83K |
| Goldman Sachs Group Inc | 13,205 | $3.04K |
| Commonwealth Equity Services, LLC | 13,500 | $3.00K |
| Avidian Wealth Solutions, LLC | 10,000 | $2.30K |
| Tower Research Capital LLC (TRC) | 8,937 | $2.06K |
| Virtu Financial LLC | 10,240 | $2.00K |
| BlackRock, Inc. | 259 | $60 |
Not filed for Q3 2025 yet (1)
Institutions that held Calidi Biotherapeutics, Inc. at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Grassi Investment Management | 10,000 | $2.00K |